Acrospire Investment Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
2017
Q2
$13K Sell
2017
Q1
$15K Sell
2016
Q4
$31K Buy
2016
Q3
$1K Sell
2016
Q2
$32K Buy